RIVM launches study on long-term effectiveness of COVID-19 vaccines RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.
Third wave shows major surge in hospital admissions in younger age groups In the week of 28 April to 4 May, there were 8% fewer new hospital admissions of people with COVID-19 compared to the week before.
First people with medical risk invited for vaccination People with a medical condition who are eligible for an annual seasonal flu vaccination will be invited for a COVID-19 vaccination in phases, starting on Thursday, 6 May.
People born in 1962 invited for COVID-19 vaccination The first people born in 1962 will be receiving an invitation for a COVID-19 vaccination this week. This group involves people who will be turning 59 this year.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
Breast milk as indicator of environmental pollutants The 6th worldwide study into Persistent Organic Pollutants (POPs) in breast milk is about to commence.
The National Immunisation Programme in the Netherlands: Developments in 2013 Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).